Journal
CROHNS & COLITIS 360
Volume 2, Issue 3, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/crocol/otaa039
Keywords
pouchitis; ileal pouch-anal anastomosis; biologic therapy
Categories
Funding
- Leona M. and Harry B. Helmsley Charitable Trust
- Crohn's and Colitis Foundation [567497]
- National Institutes of Health [P30 DK034987]
Ask authors/readers for more resources
Background: Gaps exist in our understanding of the clinical course of pouch-related disorders. Methods: We evaluated baseline disease activity and longitudinal treatment patterns among patients with inflammatory conditions of the pouch. Results: Among 468 patients with an ileal pouch-anal anastomosis (IPAA), 94 (20%) had acute pouchitis, 96 (21%) had chronic pouchitis, and 192 (41%) had Crohn disease of the pouch. Following an IPAA, 38% of patients were treated with a biologic and 11% underwent inflammatory bowel disease- or bowel-related surgery. Conclusions: Treatment patterns after IPAA indicate that pouch-related disorders have a significant impact on individual patients and the healthcare system. Lay summary In a multicenter longitudinal cohort from 7 academic centers, a significant burden of inflammatory conditions of the pouch was demonstrated after restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available